Hims & Hers Health, Inc. — Form 8-K Summary
Business context and reporting period
Hims & Hers Health, Inc. filed a Form 8-K on February 27, 2023, under Item 2.02 to announce operating results for the quarter and year ended December 31, 2022. The filing covers the company’s Class A common stock, traded on the New York Stock Exchange under the symbol HIMS.
Financial results and key metrics
The filing states that the company issued a press release announcing its quarterly and full-year 2022 results. However, the press release text and underlying financial figures are not included in the provided filing content; therefore, revenue, profit or loss, cash flow, margins, debt, liquidity, and other key metrics cannot be determined from this text.
Changes versus the prior comparable period
The filing does not provide comparative financial data or a clear description of material changes versus the prior quarter or prior year.
Guidance, outlook, risks, and unusual items
- No guidance, outlook, management commentary, risk updates, contingencies, or unusual items are described in the provided filing text.
- Exhibit 99.1 is identified as the company’s results press release, but its contents are not included.
- The reported information is furnished under Item 2.02 and is not deemed filed for purposes of Section 18 of the Exchange Act, except as expressly incorporated by reference.
Facts investors should verify
- Obtain and review Exhibit 99.1 for the reported revenue, profitability, cash flow, subscriber or customer metrics, and year-over-year comparisons.
- Verify any 2023 financial guidance or operational outlook stated in the complete press release.
- Review the company’s related periodic financial statements for debt, liquidity, cash balances, margins, and non-GAAP reconciliations.